Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Watchlisten für Ihre Werte
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON

Business Leaders

Aktuelle NewsUnternehmenMärkteWirtschaft & ForexRohstoffeZinssätzeBusiness LeadersInstitutionelle AnlegerTermineSektoren 
HomeAlle NewsMeistgelesene ArtikelBusiness Leaders Biografien
Portrait de Laurie H. Glimcher
Alter : 69
Vermögen : 551 728 USD
Größte Unternehmen : GlaxoSmithKline plc - Analog Devices, Inc.
Übersicht 
Founder of Quentis Therapeutics, Inc., Laurie H. Glimcher is on the board of Analog Devices, Inc., GlaxoSmithKline Plc and Dana-Farber and President, Chief Executive Officer & Trustee at Dana-Farber Cancer Institute, Inc., Member of Cancer Research Institute, Member of American Society of Clinical Oncology, Member of National Academy of Sciences, Member of American Academy of Arts & Sciences, Member of National Academy of Medicine (United States), Member of American Philosophical Society, Member of American Association for Cancer Research, Member of The American Association of Immunologists, Professor at Harvard Medical School, Member of American Asthma Foundation, Member of Association of American Cancer Institutes and Member of The Parker Institute For Cancer Immunotherapy.

In her past career she held the position of Director at Memorial Sloan-Kettering Cancer Center, Professor at Weill Cornell Medical College, Professor at Harvard T.H. Chan School of Public Health and Member of American Association of Physicians of Indian Origin.

Dr. Glimcher received an undergraduate degree from Radcliffe College and a doctorate from Harvard Medical School.


Aktuelle Stellungen und Verantwortungsbereiche Laurie H. Glimcher 
NameTitel Seit
GlaxoSmithKline plc
(Pharmazeutika)
Independent Non-Executive Director 2017
Analog Devices, Inc.
(Halbleiter )
Independent Director 2020
Dana-Farber Cancer Institute, Inc. President, Chief Executive Officer & Trustee 2016
Dana-Farber/Harvard Cancer Center Director -
Cancer Research Institute Member -
American Society of Clinical Oncology Member -
National Academy of Sciences Member -
American Academy of Arts & Sciences Member -
National Academy of Medicine (United States) Member -
American Philosophical Society Member -
American Association for Cancer Research Member -
The American Association of Immunologists Member -
Harvard Medical School Professor -
American Asthma Foundation Member -
Association of American Cancer Institutes Member -
The Parker Institute For Cancer Immunotherapy Member -


Anteile an Laurie H. Glimcher 
NameAktien%Wert
GlaxoSmithKline plc (GSK)
(Pharmazeutika)
20 5080,0004%446 266 USD
Analog Devices, Inc. (ADI)
(Halbleiter )
6000,0001%105 462 USD


Laurie H. Glimcher: Persönliches Netzwerk 
Meistgelesene News 
18.01.ELON MUSK : Telsa-Investoren drängen Richter, Musk zur Rückzahlung von 13 Mrd. Dollar für SolarCity-Deal anzuweisen
MR
11.01.JAMIE DIMON : JPMorgan's Dimon sagt, dass es 6-9 Monate dauern kann, bis sich das Wachstum der Verbraucherkredite wieder normalisiert
MR
14.01.JACK DORSEY : Jack Dorseys Block will ein offenes Bitcoin-Schürfsystem aufbauen
MR
14.01.ELON MUSK : Tesla-Waren können mit Dogecoin gekauft werden, sagt Musk in einem Tweet
MR
20.01.ALAN JOPE : Unilever-Aktien steigen nach der Entscheidung, das Angebot für GSK-Vermögenswerte nicht zu erhöhen
MR
12.01.MARTIN SORRELL : Sorrells S4 übertrifft die Prognosen bei weitem
MR
24.01.NELSON PELTZ : Insider - Hedgefonds-Manager Peltz nimmt sich Unilever vor
RE
19.01.HAL BARRON : GSK-Chefwissenschaftler Barron wechselt zu US-Biotech-Start-up
MR
12.01.GORDON RISKE : Mit neuem Chef ins neue Jahr
DP
25.01.JOHN HESS : Hess erhöht Produktionskapitalbudget um 37%
MR
Weitere Nachrichten und Newsletter


© 2022 People and Ownership :   
Laurie H. Glimcher : Verbindungen